G-FET - Page 2

Graphenea launched two new products out of its Graphene Foundry, which they call mGFET or miniGFET. These are Graphenea's highest value-chain products, which are manufactured and packaged in chip carriers, and can be used together with the freshly released Graphenea Card for seamless sensor development.

The mGFET is available from $99, and as it is a fully-package device, it is ready to be integrated into standard electronics. Order volume can range from a few devices for early prototyping, to JEDEC trays with hundreds of devices which are compatible with automated pick & place routines.

This is a sponsored post by Graphenea

Graphenea has announced that, following the release of its GFET S30, it has developed a High-K Metal Gate (HKMG) manufacturing process to create Field-Effect Transistor (FET) structures on graphene, or GFETs. This process is now available under the dedicated GFAB service, starting February 2022.

HKMG structures triggered a revolution in Si electronics when they were introduced during the early 2000’s, creating an alternative to SiO2 gate dielectrics that paved the way for further scaling. HKMG technology indeed enabled Moore’s law to continue, providing increased capacitance and lower current leakage than the previously state-of-the-art SiO2 tech. The most common FET architecture to modulate the conductance in graphene uses a SiO2 gate dielectric grown on top of a heavily doped Si substrate. Whereas this structure is easy to implement, it suffers from excessive current leakage when the SiO2 layer is thinned down, often rendering devices unusable. Moreover, the substrate acts as a global backgate, forbidding manipulation of individual GFET devices, which is essential for many applications.

Researchers from Boston College, Boston University, and Giner Labs have designed a small graphene-based multiplexed bio-sensor that detects opioid byproducts in wastewater.

The novel device uses graphene-based field effect transistors to detect four different synthetic and natural opioids at once, while shielding them from wastewater’s harsh elements. When a specific opioid metabolite attaches to a molecular probe on the graphene, it changes the electrical charge on the graphene. These signals are easily read electronically for each probe attached to the device.

This is a sponsored post by Graphenea

Graphenea has obtained ISO 13485 certification for manufacturing medical device components. The certification relates to the GFET product line and the Graphene Foundry service.

The ISO standard is an important certification needed for the commercialization of medical applications of graphene, in particular non-implantable biosensors. Graphenea obtained certification for the entire process chain, including raw materials, design, development, manufacture and sale. The certificate also applies to facilities, quality management, tracing, and data analysis. The ISO certificate was issued after an independent audit by SGS.

Korean researchers have developed a graphene-based field-effect transistor-based biosensor that detects SARS-CoV-2 in nasopharyngeal swabs from patients with COVID-19, in less than one minute.

Currently, most diagnostic tests for COVID-19 rely on a technique called real-time reverse transcription-polymerase chain reaction (RT-PCR), which amplifies SARS-CoV-2 RNA from patient swabs so that tiny amounts of the virus can be detected. However, the method takes at least 3 hours, including a step to prepare the viral RNA for analysis. Edmond Changkyun Park, Seung Il Kim and colleagues wanted to develop a faster diagnostic test that could analyze patient samples directly from a tube of buffer containing the swabs, without any sample preparation steps.

BioMed X has announced the completion of its first research collaboration project with Roche Diagnostics in the field of nanomaterial-based biosensors for near patient testing. BioMed X successfully achieved the proof of principle for a new sensor platform allowing the analysis of several different parameters from blood samples with one single device.

The project was initiated in 2015 as a call for application using BioMed X’s proprietary crowdsourcing platform for project proposals. As a result of an international innovation challenge, a team of early-career researchers from five different countries worked in Germany on the design of a field effect transistor-based multimodal sensing platform for proteins, blood gases and electrolytes, metabolites and enzymes with a single-use disposable material for point-of-care diagnostics.

Researchers from the University of Texas at Austin, in collaboration with Aixtron developed a new method to grow high-quality wafer-scale (300 mm) graphene sheets. This process may enable the integration of graphene with Silicon CMOS and pave the way towards graphene-based electronics.

The method is based on CVD growth on polycrystalline copper film coated silicon substrates. They report that their graphene has better charge carrier transport characteristics compared to previously synthesized poly- or single-crystalline wafers. The graphene has few defects and covers over 96% of the 300-mm wafer substrate.

In July 2014, Graphene Frontier launched the "six sensors" brand for highly-sensitive chemical and biological GFET-based sensors following a financing round of $1.6 million. Graphene Frontiers announced a partnership with the Colleges of Nanoscale Science and Engineering (CNSE) at SUNY Polytechnic Institute (SUNY Poly) to develop next generation graphene-based processes, technologies, and techniques.

Graphene Frontiers G-FET sensor

As part of the partnership, Graphene Frontiers and the CNSE will build a 300 mm fabrication process and wafer-transfer facility. The total investment in this project will reach $5 million over 3 years (and will be funded by the CNSE and Graphene Frontiers) and the project will employ 27 employees.

Researchers from the University of Pennsylvania demonstrated a graphene-based mutli-modal bio-sensor that can transmit transducing protein binding events into optical, electrical, and mechanical signals.

Such a multi-modal sensor means that you can inspect a single sample and obtain information from the three properties (optical, electrical and mechanical). This could lead to a sensor that outperforms single-mode sensors even if each signal detection by itself is not the best one. The researchers say that their sensor achieves a 100-times improvement in the sensing dynamic range over current single-mode sensors.

Two weeks ago, Graphene Frontier announced that they raised $1.6 million, which will be used to expand operations and accelerate the development of their proprietary GFET sensors and manufacturing process. Graphene Frontiers launched the "six sensors" brand for highly-sensitive chemical and biological GFET-based sensors that can be used to diagnose diseases with multiple markers such as cancers and illnesses currently diagnosed using ELISA technologies.

I asked the company to explain a little more on this interesting new sensor platform. It turns out that the sensor is based on a functionalized graphene field effect transistor (GFET). The unique properties of graphene enable detection of molecules in femtomolar (fM) concentrations - this is vastly better than any other sensor on the market.